Literature DB >> 2423040

Neurodevelopmental assessment after congenital cytomegalovirus infection.

K N Pearl, P M Preece, A Ades, C S Peckham.   

Abstract

The neurodevelopmental state of 41 children with congenital cytomegalovirus infection and their controls was assessed at 2 years using the Griffiths scale. The scores achieved by children with congenital cytomegalovirus but with no associated neurological abnormality (asymptomatic) were similar to those of the control children, whereas the mean score of the five children with congenital infection and neurological impairment (symptomatic) was significantly lower. This study, which has the statistical power to detect differences in developmental quotient as small as five points, gave no evidence that at 2 years cytomegalovirus infection was associated with mental retardation in the absence of other neurological impairment. Thus 90% of children with congenital cytomegalovirus infection at 2 years are neurologically and developmentally normal.

Entities:  

Mesh:

Year:  1986        PMID: 2423040      PMCID: PMC1777753          DOI: 10.1136/adc.61.4.323

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Inapparent congenital cytomegalovirus infection. A follow-up study.

Authors:  M L Kumar; G A Nankervis; E Gold
Journal:  N Engl J Med       Date:  1973-06-28       Impact factor: 91.245

2.  Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency.

Authors:  D W Reynolds; S Stagno; K G Stubbs; A J Dahle; M M Livingston; S S Saxon; C A Alford
Journal:  N Engl J Med       Date:  1974-02-07       Impact factor: 91.245

3.  Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection.

Authors:  P D Griffiths; S Stagno; R F Pass; R J Smith; C A Alford
Journal:  J Infect Dis       Date:  1982-05       Impact factor: 5.226

4.  Congenital cytomegalovirus infection.

Authors:  P M Preece; K N Pearl; C S Peckham
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

5.  Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up.

Authors:  R F Pass; S Stagno; G J Myers; C A Alford
Journal:  Pediatrics       Date:  1980-11       Impact factor: 7.124

6.  The outcome in children with congenital cytomegalovirus infection. A longitudinal follow-up study.

Authors:  S Saigal; O Lunyk; R P Larke; M A Chernesky
Journal:  Am J Dis Child       Date:  1982-10

7.  School failure and deafness after "silent" congenital cytomegalovirus infection.

Authors:  J B Hanshaw; A P Scheiner; A W Moxley; L Gaev; V Abel; B Scheiner
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

  7 in total
  5 in total

1.  Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data.

Authors:  A E Ades
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

2.  Diagnosis and prevention of congenital and perinatal infections.

Authors:  J M Best; S Sutherland
Journal:  BMJ       Date:  1990-10-20

3.  Intelligence and Academic Achievement With Asymptomatic Congenital Cytomegalovirus Infection.

Authors:  Adriana S Lopez; Tatiana M Lanzieri; Angelika H Claussen; Sherry S Vinson; Marie R Turcich; Isabella R Iovino; Robert G Voigt; A Chantal Caviness; Jerry A Miller; W Daniel Williamson; Craig M Hales; Stephanie R Bialek; Gail Demmler-Harrison
Journal:  Pediatrics       Date:  2017-11       Impact factor: 7.124

4.  Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom.

Authors:  Claire L Townsend; Marianne Forsgren; Karin Ahlfors; Sten-Anders Ivarsson; Pat A Tookey; Catherine S Peckham
Journal:  Clin Infect Dis       Date:  2013-01-18       Impact factor: 9.079

5.  Congenital human cytomegalovirus infection and neurologic diseases in newborns.

Authors:  Xin-Yan Zhang; Feng Fang
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.